The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.
AZoLifeSciences on MSN
Expanding CRISPR to tackle incurable skin diseases
Gene-editing techniques such as CRISPR have enabled new treatments for previously incurable diseases. Researchers at the ...
DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...
Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...
Caffeine could act as an on-off switch for gene and cell therapies, giving doctors more precise control over powerful ...
Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...
The company, founded by UC Berkeley scientists including Jennifer Doudna, is preparing to test its lead candidate STX-1150 in ...
Venkatesan Sundaresan, a Distinguished Professor of plant biology and plant sciences at the University of California, Davis, ...
Intellia is instituting new safeguards following the death of a study participant that led regulators to pause two trials in ...
AZoLifeSciences on MSN
Melbourne scientists use AI to tame CRISPR
Last year a ten-month old baby in the US was the first person in the world to have their rare genetic disease effectively ...
Dr. Hong Li, professor in Van Andel Institute’s Department of Structural Biology, leverages CRISPR, cryo-EM and other leading-edge technologies to explore the mechanisms underlying RNA-mediated ...
Intellia’s engagement with FDA is ongoing regarding the clinical hold on the IND for the MAGNITUDE Phase 3 clinical trial of nex-z for patients with transthyretin amyloidosis with cardiomyopathy (ATTR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results